OBJECTIVE: Synovitis is a feature of knee osteoarthritis (OA) and meniscal tear and has been associated with articular cartilage damage. This study was undertaken to examine the associations of baseline effusion-synovitis and changes in effusion-synovitis with changes in cartilage damage in a cohort with OA and meniscal tear. METHODS: We analyzed data from the Meniscal Tear in Osteoarthritis Research (MeTeOR) trial of surgery versus physical therapy for treatment of meniscal tear. We performed semiquantitative grading of effusion-synovitis and cartilage damage on magnetic resonance imaging, and dichotomized effusion-synovitis as none/small (minimal) and medium/large (extensive). We assessed the association of baseline effusion-synovitis and changes in effusion-synovitis with changes in cartilage damage size and depth over 18 months, using Poisson regression models. Analyses were adjusted for patient demographic characteristics, treatment, and baseline cartilage damage. RESULTS: We analyzed 221 participants. Over 18 months, effusion-synovitis was persistently minimal in 45.3% and persistently extensive in 21.3% of the patients. The remaining 33.5% of the patients had minimal synovitis on one occasion and extensive synovitis on the other. In adjusted analyses, patients with extensive effusion-synovitis at baseline had a relative risk (RR) of progression of cartilage damage depth of 1.7 (95% confidence interval [95% CI] 1.0-2.7). Compared to those with persistently minimal effusion-synovitis, those with persistently extensive effusion-synovitis had a significantly increased risk of progression of cartilage damage depth (RR 2.0 [95% CI 1.1-3.4]). CONCLUSION: Our findings indicate that the presence of extensive effusion-synovitis is associated with subsequent progression of cartilage damage over 18 months. The persistence of extensive effusion-synovitis over time is associated with the greatest risk of concurrent cartilage damage progression.
OBJECTIVE:Synovitis is a feature of knee osteoarthritis (OA) and meniscal tear and has been associated with articular cartilage damage. This study was undertaken to examine the associations of baseline effusion-synovitis and changes in effusion-synovitis with changes in cartilage damage in a cohort with OA and meniscal tear. METHODS: We analyzed data from the Meniscal Tear in Osteoarthritis Research (MeTeOR) trial of surgery versus physical therapy for treatment of meniscal tear. We performed semiquantitative grading of effusion-synovitis and cartilage damage on magnetic resonance imaging, and dichotomized effusion-synovitis as none/small (minimal) and medium/large (extensive). We assessed the association of baseline effusion-synovitis and changes in effusion-synovitis with changes in cartilage damage size and depth over 18 months, using Poisson regression models. Analyses were adjusted for patient demographic characteristics, treatment, and baseline cartilage damage. RESULTS: We analyzed 221 participants. Over 18 months, effusion-synovitis was persistently minimal in 45.3% and persistently extensive in 21.3% of the patients. The remaining 33.5% of the patients had minimal synovitis on one occasion and extensive synovitis on the other. In adjusted analyses, patients with extensive effusion-synovitis at baseline had a relative risk (RR) of progression of cartilage damage depth of 1.7 (95% confidence interval [95% CI] 1.0-2.7). Compared to those with persistently minimal effusion-synovitis, those with persistently extensive effusion-synovitis had a significantly increased risk of progression of cartilage damage depth (RR 2.0 [95% CI 1.1-3.4]). CONCLUSION: Our findings indicate that the presence of extensive effusion-synovitis is associated with subsequent progression of cartilage damage over 18 months. The persistence of extensive effusion-synovitis over time is associated with the greatest risk of concurrent cartilage damage progression.
Authors: Carla R Scanzello; Brian McKeon; Bryan H Swaim; Edward DiCarlo; Eva U Asomugha; Veero Kanda; Anjali Nair; David M Lee; John C Richmond; Jeffrey N Katz; Mary K Crow; Steven R Goldring Journal: Arthritis Rheum Date: 2011-02
Authors: D T Felson; J Niu; T Neogi; J Goggins; M C Nevitt; F Roemer; J Torner; C E Lewis; A Guermazi Journal: Osteoarthritis Cartilage Date: 2015-09-30 Impact factor: 6.576
Authors: Frank W Roemer; C Kent Kwoh; Michael J Hannon; Michel D Crema; Carolyn E Moore; John M Jakicic; Stephanie M Green; Ali Guermazi Journal: Eur J Radiol Date: 2010-09-15 Impact factor: 3.528
Authors: M D Crema; F W Roemer; L Li; R C Alexander; I P Chessell; A D Dudley; R Karlsten; L B Rosen; A Guermazi Journal: Osteoarthritis Cartilage Date: 2016-09-30 Impact factor: 6.576
Authors: Jeffrey N Katz; Christine E Chaisson; Brian Cole; Ali Guermazi; David J Hunter; Morgan Jones; Bruce A Levy; Lisa A Mandl; Scott Martin; Robert G Marx; Clare Safran-Norton; Frank W Roemer; Debra Skoniecki; Daniel H Solomon; Kurt P Spindler; John Wright; Rick W Wright; Elena Losina Journal: Contemp Clin Trials Date: 2012-09-05 Impact factor: 2.226
Authors: Ali Guermazi; Daichi Hayashi; Frank W Roemer; Yanyan Zhu; Jingbo Niu; Michel D Crema; M Kassim Javaid; Monica D Marra; John A Lynch; George Y El-Khoury; Yuqing Zhang; Michael C Nevitt; David T Felson Journal: J Rheumatol Date: 2014-01-15 Impact factor: 4.666
Authors: Frank W Roemer; Yuqing Zhang; Jingbo Niu; John A Lynch; Michel D Crema; Monica D Marra; Michael C Nevitt; David T Felson; Laura B Hughes; George Y El-Khoury; Martin Englund; Ali Guermazi Journal: Radiology Date: 2009-07-27 Impact factor: 11.105
Authors: F W Roemer; A Guermazi; D J Hunter; J Niu; Y Zhang; M Englund; M K Javaid; J A Lynch; A Mohr; J Torner; C E Lewis; M C Nevitt; D T Felson Journal: Osteoarthritis Cartilage Date: 2008-10-17 Impact factor: 6.576
Authors: Tonia L Vincent; Tamara Alliston; Mohit Kapoor; Richard F Loeser; Linda Troeberg; Christopher B Little Journal: Clin Geriatr Med Date: 2022-05 Impact factor: 3.529
Authors: Eleonora Olivotto; Elisa Belluzzi; Assunta Pozzuoli; Augusto Cigolotti; Manuela Scioni; Steven R Goldring; Mary B Goldring; Pietro Ruggieri; Roberta Ramonda; Brunella Grigolo; Giovanni Trisolino; Marta Favero Journal: Int J Mol Sci Date: 2022-03-31 Impact factor: 5.923
Authors: Eleonora Olivotto; Giovanni Trisolino; Elisa Belluzzi; Antonello Lazzaro; Alessandro Strazzari; Assunta Pozzuoli; Augusto Cigolotti; Pietro Ruggieri; Andrea Evangelista; Francesca Ometto; Stefano Stallone; Steven R Goldring; Mary B Goldring; Roberta Ramonda; Brunella Grigolo; Marta Favero Journal: J Clin Med Date: 2022-07-26 Impact factor: 4.964